This article is a correction to:
A zebrafish model of Ifih1-driven Aicardi–Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients
Beatriz Bernal-Bermúdez1,2,3‡
Alicia Martínez-López2,3*‡Francisco J. Martínez-Morcillo1,2,3†
Sylwia D. Tyrkalska1,2,3Teresa Martínez-Menchón2,3,4
Pablo Mesa-del-Castillo2,3,4María L. Cayuela2,3,4
Victoriano Mulero1,2,3Diana García-Moreno2,3*- 1Departamento de Biología Celular e Histología, Facultad de Biología, Universidad de Murcia, Murcia, Spain
- 2Instituto Murciano de Investigación Biosanitaria (IMIB)-Pascual Parrilla, Murcia, Spain
- 3Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain
- 4Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain
A Corrigendum on
A zebrafish model of Ifih1-driven Aicardi–Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients
By Bernal-Bermúdez B, Martínez-López A, Martínez-Morcillo FJ, Tyrkalska SD, Martínez-Menchón T, Mesa-del-Castillo P, Cayuela ML, Mulero V and García-Moreno D (2023) Front. Immunol. 14:1294766. doi: 10.3389/fimmu.2023.1294766
In the published article, there was an error in the Funding statement. The research grant which appeared in the published Funding statement was incorrect. The correct Funding statement appears below.
“The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study has been funded by Instituto de Salud Carlos III (ISCIII) through the project “CP21/00028” and research grant PI22/00879 and co-funded by the European Union to DG-M) and Consejería de Salud de la Región de Murcia (ZEBER project to MC and VM), Spanish Ministry of Science and Innovation (Juan de la Cierva-Incorporacion postdoctoral contract to ST). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: type I IFN, IFIH1, zebrafish avatar, autoimmunity, drug screening
Citation: Bernal-Bermúdez B, Martínez-López A, Martínez-Morcillo FJ, Tyrkalska SD, Martínez-Menchón T, Mesa-del-Castillo P, Cayuela ML, Mulero V and García-Moreno D (2025) Corrigendum: A zebrafish model of Ifih1-driven Aicardi–Goutières syndrome reproduces the interferon signature and the exacerbated inflammation of patients. Front. Immunol. 15:1544703. doi: 10.3389/fimmu.2024.1544703
Received: 13 December 2024; Accepted: 16 December 2024;
Published: 06 January 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Bernal-Bermúdez, Martínez-López, Martínez-Morcillo, Tyrkalska, Martínez-Menchón, Mesa-del-Castillo, Cayuela, Mulero and García-Moreno. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Alicia Martínez-López, YWxpY2lhLm1hcnRpbmV6MzRAdW0uZXM=; Diana García-Moreno, ZGlhbmEuZ2FyY2lhQGltaWIuZXM=
†Present address: Francisco J. Martínez-Morcillo, Institute for Developmental Biology, Matthias Hammerschmidt Lab, Cologne University, Koeln, Germany
‡These authors have contributed equally to this work